Luiz O F Penalva (Luiz O Penalva)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Virginia Giolito, Serguei Bodoirat, Theo La Rosa, Mathieu Reslinger, Gabriela D A Guardia, Jana Mourtada, Leo Claret, Alain Joung, Pedro A F Galante, Luiz O F Penalva, Michelina Plateroti
Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies. Cell death & disease 15 (5) (2024)
Maria Virginia Giolito, Serguei Bodoirat, Theo La Rosa, Mathieu Reslinger, Gabriela D A Guardia, Jana Mourtada, Leo Claret, Alain Joung, Pedro A F Galante, Luiz O F Penalva, Michelina Plateroti
Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies. Cell death & disease 15 (5) (2024)
Maria Virginia Giolito, Serguei Bodoirat, Theo La Rosa, Mathieu Reslinger, Gabriela D A Guardia, Jana Mourtada, Leo Claret, Alain Joung, Pedro A F Galante, Luiz O F Penalva, Michelina Plateroti
Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies. Cell death & disease 15 (5) (2024)
Maria Virginia Giolito, Serguei Bodoirat, Theo La Rosa, Mathieu Reslinger, Gabriela D A Guardia, Jana Mourtada, Leo Claret, Alain Joung, Pedro A F Galante, Luiz O F Penalva, Michelina Plateroti
Impact of the thyroid hormone T3 and its nuclear receptor TRα1 on colon cancer stem cell phenotypes and response to chemotherapies. Cell death & disease 15 (5) (2024)
Adam Kosti, Jennifer Chiou, Gabriela D A Guardia, Xiufen Lei, Henriette Balinda, Tesha Landry, Xiyuan Lu, Mei Qiao, Andrea Gilbert, Andrew Brenner, Pedro A F Galante, Stefano Tiziani, Luiz O F Penalva
ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics. Neuro-oncology (2022)
Carla Frau, Catherine Jamard, Gaspard Delpouve, Gabriela D A Guardia, Christelle Machon, Camilla Pilati, Clémentine Le Nevé, Pierre Laurent-Puig, Jérôme Guitton, Pedro A F Galante, Luiz O F Penalva, Jean-Noël Freund, Christelle De La Fouchardière, Michelina Plateroti
Deciphering the Role of Intestinal Crypt Cell Populations in Resistance to Chemotherapy. Cancer research 81 (10) (2021)
Rebecca Pötschke, Jacob Haase, Markus Glaß, Sebastian Simmermacher, Claudia Misiak, Luiz O F Penalva, Caspar D Kühnöl, Stefan Hüttelmaier
MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation. Cancers 12 (12) (2020)
Adam Kosti, Patricia Rosa de Araujo, Wei-Qing Li, Gabriela D A Guardia, Jennifer Chiou, Caihong Yi, Debashish Ray, Fabiana Meliso, Yi-Ming Li, Talia Delambre, Mei Qiao, Suzanne S Burns, Franziska K Lorbeer, Fanny Georgi, Markus Flosbach, Sarah Klinnert, Anne Jenseit, Xiufen Lei, Carolina Romero Sandoval, Kevin Ha, Hong Zheng, Renu Pandey, Aleksandra Gruslova, Yogesh K Gupta, Andrew Brenner, Erzsebet Kokovay, Timothy R Hughes, Quaid D Morris, Pedro A F Galante, Stefano Tiziani, Luiz O F Penalva
The RNA-binding protein SERBP1 functions as a novel oncogenic factor in glioblastoma by bridging cancer metabolism and epigenetic regulation. Genome biology 21 (1) (2020)

Luiz O F Penalva.css-eqlu8i{font-size:small;padding-left:4px;} (Luiz O Penalva)

Publication Activity (10 Years)

Top Topics

Top Venues

Luiz O F Penalva (Luiz O Penalva)